The DES Center

Filter Your Results

 

News

 

Clinical Study of Medtronic's Resolute Onyx 2.0-mm DES for Extra Small Vessels Meets Primary Endpoint

May 18, 2017 -- Medtronic announced that the Resolute Onyx 2.0-mm drug-eluting stent (DES) met its primary endpoint of target lesion failure (TLF) at 1 year for the treat…

Biotronik's Magmaris Resorbable Scaffold Shows Reduced Risk of Thrombosis

May 17, 2017 -- Biotronik announced data demonstrating that the company's Magmaris resorbable scaffold offers a reduced risk of thrombus formation compared with a polymeri…

Micell's MiStent Achieves Primary Endpoint in All-Comers DESSOLVE III Trial

May 16, 2017 -- Micell Technologies, Inc. announced that positive 12-month data from its DESSOLVE III clinical trial were presented by Prof. Robbert J. de Winter, MD, dur…

Shockwave Medical's Coronary Lithoplasty System Receives CE Mark Approval

May 15, 2017 -- Shockwave Medical, Inc. announced European CE Mark approval for the company’s coronary Lithoplasty system for the treatment of calcified p…

Long-Term Safety and Efficacy of Bioresorbable Vascular Scaffolds Versus Metallic Stents Compared in Meta-Analysis

May 8, 2017 -- A meta-analysis of randomized trials evaluating the long-term safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds (BVS) versus everolimus…

Medtronic Launches Resolute Onyx Drug-Eluting Stent in United States

May 1, 2017 -- Medtronic announced the US Food and Drug Administration (FDA) approval and the United States launch of the Resolute Onyx drug-eluting stent (DES). The Reso…

DUTCH PEERS Data Evaluate Newer-Generation DES at 3 Years

April 24, 2017 -- A report assessing the 3-year safety and efficacy of implanting newer-generation Resolute Integrity zotarolimus-eluting stents (ZES; Medtronic) versus P…

Reva Medical's Fantom Bioresorbable Coronary Scaffold Approved in Europe

April 10, 2017 -- Reva Medical, Inc. announced it has received European CE Mark approval for its Fantom drug-eluting bioresorbable coronary scaffold. Fantom is Reva’s fi…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.